Use the Search Fields to Find Information
Page 71 of 360
Review of the Endocannabinoid System
Please use this link to access this publication. Abstract The endocannabinoid system (ECS) is a widespread neuromodulatory network involved in the developing central nervous system
April 19, 2024
Review of cannabis use and propofol anesthesia: recent insights and clinical implications
Please use this link to access this publication. Abstract Purpose of review We examine recent evidence and clinical implications of pharmacological interactions between cannabis and
November 20, 2025
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
Please use this link to access this publication. Abstract This study was designed to test our hypothesis that an ultra-low dose of delta-9 tetrahydrocannabinol (THC) reverses age-dependent cognitive
September 4, 2024
Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults
Abstract Introduction Cannabis is the most commonly used illicit substance in the United States, and nearly 1 in 4 young adults are current cannabis users.
August 2, 2025
Residual Effects of Cannabis Use on Effort-Based Decision-Making
Please use this link to access this publication. Abstract Objective:Acute Δ9-tetrahydrocannabinol (THC) administration in humans (Lawn etal., 2016) and rats (Silveira, Adams, Morena, Hill, & Winstanley, 2016)
August 21, 2025
Research design concerns in a retrospective analysis of neurological disorders and cannabis abuse
Please use this link to access this publication.
February 22, 2026
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Abstract Background: Emerging evidence supports cannabidiol (CBD) as a promising therapeutic compound for various health conditions, despite its approval as a medication (product for medical
December 21, 2025
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This
September 19, 2019
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation
Abstract This narrative review explores the benefits and risks of cannabinoids in kidney health, particularly in individuals with pre-existing renal conditions. It discusses the roles
February 22, 2026
Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease
Abstract Neuropathic pain is one of the most invalidating symptoms in patients with Fabry disease (FD), affecting their quality of life, it is linked to small fiber
December 7, 2023
Page 71 of 360